Does Remicade Cause Allergic Reactions During Infusion?
Yes, Remicade (infliximab) can cause allergic reactions during or within 1-2 hours after infusion. These range from mild symptoms like itching, rash, fever, chills, dyspnea, or hypotension to severe anaphylaxis, including laryngeal edema, bronchospasm, or shock. Reactions occur in about 20% of patients overall, with acute infusion reactions in 3-22% depending on the study and patient population.[1][2]
Why Do Reactions Happen During Infusion?
Infliximab is a monoclonal antibody that triggers immune responses, especially on first or second exposure (human antichimeric antibody formation). Cytokine release or IgE-mediated hypersensitivity contributes. Reactions are more common with rapid infusions or in patients with prior exposure.[1][3]
How Common Are They, and Who's at Risk?
- First infusion: <1% severe reactions.
- Subsequent infusions: Up to 3% acute severe events.
Higher risk in patients with Crohn's disease, asthma history, or concurrent immunomodulators. Pediatric rates mirror adults.[1][2]
What Happens If a Reaction Occurs?
Mild cases resolve with slowed infusion, acetaminophen, antihistamines, or steroids. Severe reactions require immediate stopping, epinephrine, oxygen, or hospitalization. Fatalities are rare but reported (<0.01%). Premedication (steroids, antihistamines) reduces risk by 50-70% in high-risk patients.[1][3]
How to Prevent Reactions
Start with supervised infusions in a medical setting. Guidelines recommend 2-hour initial infusions, premedication for re-inductions, and monitoring vital signs. Switch to subcutaneous alternatives like Inflectra if tolerated.[1][2]
Differences with Biosimilars Like Inflectra or Renflexis
Biosimilars have similar reaction profiles (2-10% acute rates), but some data show slightly lower immunogenicity due to manufacturing tweaks. No head-to-head trials prove superiority.[2]
[1]: FDA Remicade Label
[2]: DrugPatentWatch.com - Remicade Patents and Litigation (includes safety data summaries)
[3]: Janssen Remicade Prescribing Information